Fool.com
The World's Greatest Investing Community
Results 51 - 60 of 608 : Previous 2 3 4 5 6 7 8 9 10 Next
A Big Upgrade for Teva Pharmaceutical
This bullish call comes from more than just one analyst.
Healthy Spinoffs, Happy Investors
When medical companies spin off unwanted divisions, the spinoffs can outperform the parent.
A Big Upgrade for Tenet Healthcare
This bullish call comes from more than just one analyst.
Don't Count on These Investments to Save You
These alternative funds didn't deliver on their promises.
It's the most important stock you can own.
Warning: Potential Blockbuster Ahead
It'll enter a crowded market, but there's plenty to go around.
Investors dish out undue punishment to Onyx.
Here We Go Again With Possible Side Effects
Merck is the newest victim.
Your Ticket to Country Club Riches
And how to flaunt your flip-flops in front of royalty.
Drugmakers' HIV Treatments Live On
A vaccine doesn't look like an imminent threat to revenue.
Legal Information © 1995 - 2009 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK